New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

Researchers at LSU’s Pennington Biomedical Research Center are working with the Lancet Commission on Clinical Obesity, in ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

-- Most important technology trends: AI, robotics, space, autonomous vehicles, crypto, the app economy and social media. -- Most important macroeconomic trends: Higher interest rates, higher inflation ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Cardiovascular disease is responsible for around one third of deaths globally and killed more than 20 million people in 2021 ...